Skip to main content

Lebel Francois's Form 4 filing

Spectrum Pharmaceuticals Inc (SPPI) · filed Jun 23, 2022

Accession no.
0001209191-22-039063
Filed
Jun 23, 2022
Trade date
Jun 21-23, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $10.5K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lebel FrancoisCIK 0001038704Officer (Chief Medical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 21, 2022Common Stock, $0.001 par valueAGrant or awardAcquired+405,040$0.00$0657,553Direct
Jun 22, 2022Common Stock, $0.001 par valueSSaleDisposed−6,096$0.81−$4,937.76651,457Direct
Jun 23, 2022Common Stock, $0.001 par valueSSaleDisposed−6,667$0.84−$5,600.28644,790Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 21, 2022Common StockAGrant or awardAcquired+1,488,940$0.00$01,488,940Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)